Monoclonal Antibody Receives Expanded Authorized Usage From FDA
August 4th 2021With the FDA nod, Regeneron’s monoclonal antibody Regen-Cov (casirivimab and imdevimab) is authorized for the use of the therapy for post-exposure prophylaxis in certain people exposed to SARS-CoV-2 or who are at high risk of exposure to an infected individual.
A Clinical Decision Support Strategy Boosted Influenza Vaccination Rates Among Hospitalized Children
July 30th 2021A clinical decision support (CDS) strategy including a default influenza vaccine order for eligible patients, a nursing script using a presumptive strategy, and education for clinicians, was associated with significant improvement in vaccination rates among hospitalized children, a new study showed.
Pfizer Positions Itself for Booster COVID-19 Vaccine Development
July 29th 2021With its latest earnings report showing the financial impact of the vaccine, the Delta variant becoming the dominant strain in the US, and concerns of waning immunity, the company believes there is evidence for an additional booster shot.